Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v3-EN | Version v3-EN | |
|---|---|---|
| Language | English | English |
| Date Updated | 2019-03-30 | 2019-03-30 |
| Drug Identification Number | 00038121 | 00038121 |
| Brand name | EPHEDRINE SULFATE INJECTION USP | EPHEDRINE SULFATE INJECTION USP |
| Common or Proper name | EPHEDRINE SULFATE INJECTION USP | EPHEDRINE SULFATE INJECTION USP |
| Company Name | PFIZER CANADA ULC | PFIZER CANADA ULC |
| Ingredients | EPHEDRINE SULFATE | EPHEDRINE SULFATE |
| Strength(s) | 50MG | 50MG |
| Dosage form(s) | SOLUTION | SOLUTION |
| Route of administration | INTRAMUSCULAR SUBCUTANEOUS INTRAVENOUS | INTRAMUSCULAR SUBCUTANEOUS INTRAVENOUS |
| Packaging size | 50 x 1mL | 50 x 1mL |
| ATC code | R03CA | R03CA |
| ATC description | ADRENERGICS FOR SYSTEMIC USE | ADRENERGICS FOR SYSTEMIC USE |
| Reason for discontinuation | Manufacturing issues | Manufacturing issues |
| Anticipated discontinuation date | ||
| Actual discontinuation date | 2019-03-29 | 2019-03-29 |
| Remaining supply date | 2019-03-29 | 2019-03-29 |
| Discontinuation status | Discontinued | Discontinued |
| Discontinuation decision reversal | no | no |
| Tier 3 Status | No | No |
| Information on remaining supply | ||
| Company comments | ||
| Health Canada comments |